<?xml version="1.0" encoding="UTF-8"?>
<p>Overall, nearly 30 vaccine candidates against CHIKF have been reported, but only four of these have entered Phase 1 or 2 trials [
 <xref rid="pntd.0006919.ref051" ref-type="bibr">51</xref>â€“
 <xref rid="pntd.0006919.ref053" ref-type="bibr">53</xref>] (
 <xref rid="pntd.0006919.t001" ref-type="table">Table 1</xref>). Whether any of these vaccine candidates will advance to Phase 3 trials cannot be easily predicted and will be based on the perceived market as well as the identification of a suitable site with adequate incidence of CHIKF to demonstrate efficacy.
</p>
